CASTLE BIOSCIENCES INC CEO Derek J. Maetzold exercised Options for 8,584 shares at $2.39 per share, lifting his reported share holding to 30,063. Investors also have a direct-ownership reference after 14,518 shares were sold, with 12,268 shares remaining, while derivative securities stood at 16,745.

Key Highlights

  • Maetzold sold 14,518 CASTLE BIOSCIENCES INC shares at prices from $32 to $32.78 per share.
  • The exercised options represented about 33.9% of his prior derivative-securities holding.
  • His reported holding after the sales was 12,268 shares.

CASTLE BIOSCIENCES INC (NASDAQ: CSTL) Chief Executive Officer Derek J. Maetzold exercised options for 8,584 shares at $2.39 per share on 11 September 2026. His reported share ownership after the exercise was 30,063 shares, and the transaction represented about 28.6% of that resulting holding.

Maetzold Reports Option Exercise and Share Sales

Maetzold also sold 14,518 CASTLE BIOSCIENCES INC shares at prices ranging from $32 to $32.78 per share on 11 September 2026. The transaction code M identifies the option exercise, while code S identifies the stock sales. The exercised options represented about 33.9% of Maetzold’s prior derivative-securities holding.

Direct Shares and Derivative Securities Reported Separately

The filing reports share balances and derivative-securities balances separately. Maetzold owned 12,268 shares after the sales and 16,745 derivative securities after the option exercise. The filing reports these balances as shares and derivative securities.